論文

2020年12月24日

Successful management of a patient with active Cushing‍'‍s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia.

Endocrine journal
  • Akiko Yuno
  • Yoshiyuki Kenmotsu
  • Yuka Takahashi
  • Hiroshi Nomoto
  • Hiraku Kameda
  • Kyu Yong Cho
  • Akinobu Nakamura
  • Yu Yamashita
  • Junichi Nakamura
  • Sho Nakakubo
  • Keisuke Kamada
  • Masaru Suzuki
  • Hirokazu Sugino
  • Naoko Inoshita
  • Satoshi Konno
  • Hideaki Miyoshi
  • Tatsuya Atsumi
  • Yutaka Sawamura
  • Akira Shimatsu
  • 全て表示

68
4
開始ページ
477
終了ページ
484
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1507/endocrj.EJ20-0613

We provide the details of the successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia. The patient was a 27-year-old Japanese female healthcare worker who was scheduled to undergo pituitary surgery for Cushing's disease. She had been in close contact with an undiagnosed patient infected with COVID-19 and then developed COVID-19 pneumonia. Despite a lack of known risk factors associated with severe COVID-19 infection, the patient's dyspnea worsened and her respiratory condition deteriorated, as indicated by the need for 7 L/min oxygen supply by mask to maintain her oxygen saturation at >90%. Medical treatment was initiated to control hypercortisolism by the 'block and replace' regimen using steroidogenesis inhibitors and hydrocortisone. The COVID-19 pneumonia improved with multi-modal treatment including antiviral therapy. One month later, after a negative severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) test result and with appropriate protection against virus transmission to medical staff in the operating room and daily medical care nurses, trans-sphenoidal surgery was performed by our highly experienced pituitary surgeon. One month after the surgery, the patient's basal ACTH and cortisol levels and urinary free cortisol were all under the detection limit. Surgical remission was expected. Since hypercortisolism due to active Cushing's disease may worsen a COVID-19 infection, multi-disciplinary management that includes appropriate and prompt treatment strategies is mandatory in such cases.

リンク情報
DOI
https://doi.org/10.1507/endocrj.EJ20-0613
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33361650
ID情報
  • DOI : 10.1507/endocrj.EJ20-0613
  • PubMed ID : 33361650

エクスポート
BibTeX RIS